Reposar, Jhon Rey B.

HRN: 07-39-33  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2023
CEFTAZIDIME 1GM (VIAL)
02/15/2023
02/17/2023
IV
1 Gram
Q8
T/C Sepsisi
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: